Search Results - "Kazuaki Chayama"

Refine Results
  1. 1

    Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study by Eguchi, Yuichiro, Hyogo, Hideyuki, Ono, Masafumi, Mizuta, Toshihiko, Ono, Naofumi, Fujimoto, Kazuma, Chayama, Kazuaki, Saibara, Toshiji

    Published in Journal of gastroenterology (01-05-2012)
    “…Background The prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing. This study aimed to assess the recent prevalence of NAFLD and to…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma by Hayes, C Nelson, Chayama, Kazuaki

    “…Serum levels of liver enzymes, such as alanine transaminase, aspartate transaminase, and α-fetoprotein, provide insight into liver function and are used during…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages by Cheng, Xiaoming, Xia, Yuchen, Serti, Elisavet, Block, Peter Daniel, Chung, Michelle, Chayama, Kazuaki, Rehermann, Barbara, Liang, T. Jake

    Published in Hepatology (Baltimore, Md.) (01-12-2017)
    “…Hepatitis B virus (HBV) infects hepatocytes specifically and causes immune‐mediated liver damage. How HBV interacts with the innate immunity at the early phase…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Role of tumor‐associated macrophages at the invasive front in human colorectal cancer progression by Inagaki, Katsuaki, Kunisho, Shoma, Takigawa, Hidehiko, Yuge, Ryo, Oka, Shiro, Tanaka, Shinji, Shimamoto, Fumio, Chayama, Kazuaki, Kitadai, Yasuhiko

    Published in Cancer science (01-07-2021)
    “…Macrophages are an essential component of antitumor activity; however, the role of tumor‐associated macrophages (TAMs) in colorectal cancer (CRC) remains…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Characteristics and Early Diagnosis of Gastric Cancer Discovered after Helicobacter pylori Eradication by Ito, Masanori, Tanaka, Shinji, Chayama, Kazuaki

    Published in Gut and liver (15-05-2021)
    “…The prevalence of gastric cancer after eradication (GCAE) is increasing dramatically in Japan. GCAE has characteristic features, and we must understand these…”
    Get full text
    Journal Article
  12. 12

    Road to elimination of HCV: Clinical challenges in HCV management by Hayes, C. Nelson, Imamura, Michio, Tanaka, Junko, Chayama, Kazuaki

    Published in Liver international (01-08-2022)
    “…Since its discovery in 1989, the road to a cure for hepatitis C virus (HCV) has been slow, but most patients can now expect to achieve a sustained virological…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20